We are live on ! Find out more
WRM

Weybosset Research & Management Portfolio holdings

AUM $381M
1-Year Est. Return 42.16%
This Fund
S&P 500
This Quarter Est. Return
+18.94%
1 Year Est. Return
+42.16%
3 Year Est. Return
+73.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$171M
AUM Growth
+$30.3M
Cap. Flow
-$54.9M
Cap. Flow %
-32.18%
Top 10 Hldgs %
54.26%
Holding
57
New
4
Increased
17
Reduced
23
Closed
6

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$621K
2
STZ icon
Constellation Brands
STZ
+$541K
3
HXL icon
Hexcel
HXL
+$503K
4
APTV icon
Aptiv
APTV
+$404K
5
PG icon
Procter & Gamble
PG
+$252K

Top Sells

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$54.3M
2
CPRT icon
Copart
CPRT
+$477K
3
PFE icon
Pfizer
PFE
+$410K
4
MCD icon
McDonald's
MCD
+$359K
5
MMM icon
3M
MMM
+$299K

Sector Composition

Rank Sector Weight
1 Industrials 35.92%
2 Technology 13.5%
3 Financials 13.41%
4 Healthcare 9.02%
5 Consumer Discretionary 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMZN icon
26
Amazon
AMZN
$2.94T
$819K 0.48%
5,940
– –
MSFT icon
27
Microsoft
MSFT
$3.71T
$747K 0.44%
3,673
+398
+12% +$72.2K
V icon
28
Visa
V
$692B
$607K 0.36%
3,143
-200
-6% -$36.5K
BRK.A icon
29
Berkshire Hathaway Class A
BRK.A
$1.13T
$535K 0.31%
2
-198
-99% -$54.3M
KO icon
30
Coca-Cola
KO
$374B
$519K 0.3%
11,610
-2,335
-17% -$108K
CSCO icon
31
Cisco
CSCO
$476B
$504K 0.3%
10,800
+850
+9% +$37.3K
CRM icon
32
Salesforce
CRM
$153B
$492K 0.29%
2,625
+1,000
+62% +$168K
ABBV icon
33
AbbVie
ABBV
$431B
$437K 0.26%
4,450
– –
ABT icon
34
Abbott
ABT
$187B
$434K 0.25%
4,750
– –
AMGN icon
35
Amgen
AMGN
$219B
$407K 0.24%
1,725
– –
ITW icon
36
Illinois Tool Works
ITW
$84.8B
$393K 0.23%
2,250
-300
-12% -$49K
ACN icon
37
Accenture
ACN
$105B
$386K 0.23%
1,800
– –
ARCC icon
38
Ares Capital
ARCC
$14.1B
$373K 0.22%
25,782
+635
+3% +$8.57K
STZ icon
39
Constellation Brands
STZ
$22.6B
$330K 0.19%
+3,250
New +$541K
UNP icon
40
Union Pacific
UNP
$175B
$330K 0.19%
1,950
-1,500
-43% -$240K
RTX icon
41
RTX Corp
RTX
$301B
$261K 0.15%
4,235
-902
-18% -$56.3K
PG icon
42
Procter & Gamble
PG
$342B
$258K 0.15%
+2,158
New +$252K
GOOGL icon
43
Alphabet (Google) Class A
GOOGL
$4.38T
$255K 0.15%
3,600
– –
GSBD icon
44
Goldman Sachs BDC
GSBD
$1.02B
$244K 0.14%
15,035
+1,425
+10% +$22K
ATOM icon
45
Atomera
ATOM
$206M
$239K 0.14%
26,575
-4,970
-16% -$34.1K
VFC icon
46
VF Corp
VFC
$5.8B
$229K 0.13%
+3,750
New +$218K
CTVA icon
47
Corteva
CTVA
$51.3B
$222K 0.13%
8,284
-1,599
-16% -$41.6K
CAT icon
48
Caterpillar
CAT
$395B
$209K 0.12%
1,655
-700
-30% -$83K
DIS icon
49
Walt Disney
DIS
$182B
$206K 0.12%
+1,845
New +$204K
KOPN icon
50
Kopin
KOPN
$756M
$86K 0.05%
64,545
+38,670
+149% +$32.4K
1
2
3

Similar funds

HCP
Hiddenite Capital Partners New York $381M AUM 73.07% 1-Year Est. Return
SFWC
Strategic Family Wealth Counselors Fairfield, New Jersey $381M AUM 21.36% 1-Year Est. Return
MC
Muhlenkamp & Co Wexford, Pennsylvania $380M AUM 43.74% 1-Year Est. Return
STP
Science & Technology Partners New York $382M AUM 202.26% 1-Year Est. Return
RSS
Rosenblum Silverman Sutton San Francisco, California $382M AUM 13.82% 1-Year Est. Return
DSA
Droms Strauss Advisors St. Louis, Missouri $383M AUM 17.99% 1-Year Est. Return
EAM
Empirical Asset Management Wellesley, Massachusetts $379M AUM 24.52% 1-Year Est. Return
RC
RV Capital Schindellegi, Switzerland $383M AUM 21.52% 1-Year Est. Return

Weybosset Research & Management's Q2 2020 Portfolio in Review

As of Q2 2020, Weybosset Research & Management held 57 positions worth $171M, up 22% from $140M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Weybosset Research & Management withdrew a net $54.9M in Q2 2020, closing 6 positions and reducing 23 holdings. Its most notable exit was Pfizer, an estimated $410K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 36% of assets, down from 37% a quarter earlier, followed by Technology and Financials.

Against the trend, Weybosset Research & Management opened a new position in Constellation Brands worth $330K.

  • Weybosset Research & Management's largest Q2 2020 buy was Constellation Brands: 3,250 shares worth $330K.
  • Weybosset Research & Management added most to JPMorgan Chase in Q2 2020, an estimated $621K increase.
  • Weybosset Research & Management's biggest Q2 2020 reduction was Berkshire Hathaway Class A, cutting an estimated $54.3M.
  • Weybosset Research & Management fully exited Pfizer in Q2 2020, selling an estimated $410K.
  • Weybosset Research & Management's ten largest holdings make up 54% of its $171M portfolio in Q2 2020.
  • Weybosset Research & Management opened 4 new positions and closed 6 in Q2 2020.
  • Weybosset Research & Management's portfolio value rose 22% quarter-over-quarter to $171M.

Based on Weybosset Research & Management's 13F filing for Q2 2020, filed 22 Jul 2020.